- CME was the perfect stock for monetary policy tightening and a commodity surge in the US economy;
- The stock peaked at $251 in late March '22 and has traded all the way down to its 200-week moving average for a 26% correction in the last 8 weeks;
- In late 2018, when the market began to sniff out that Jay Powell would have to reverse his tighter monetary policy, CME corrected 18% from $197 down to $161;
- Free-cash-flow is consistently 95% of CME's cash-flow (a definite positive), but no stock is repurchased, rather a "variable dividend" is paid to shareholders every year.
For further details see:
CME Nears A Do-Or-Die Moment